Connor, Clark & Lunn Investment Management (CC&L)
LJPC

Connor, Clark & Lunn Investment Management (CC&L)’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,094
Closed -$40K – 1270
2021
Q3 		$40K Buy
+10,094
New +$40.1K ﹤0.01% 1012

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s LJPC Position: Q4 2021 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2021, closing a stake of 10,094 shares — an estimated $40K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in LJPC in Q3 2021 and held it in 1 quarter. The position peaked at $40K in Q3 2021. 44 funds tracked by Wall St. Rank hold LJPC as of Q4 2021.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining La Jolla Pharmaceutical Company position as of Q4 2021 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 10,094 La Jolla Pharmaceutical Company shares in Q4 2021, an estimated $40K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in La Jolla Pharmaceutical Company in Q3 2021 and held it in 1 quarter.
  • Connor, Clark & Lunn Investment Management (CC&L)'s La Jolla Pharmaceutical Company position peaked at $40K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2021.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2021, filed 10 Feb 2022.